Abstract
Synaptosomal gamma-aminobutyric acid (GABA) uptake has been used as a biochemical marker for GABAergic terminals in controls and Alzheimer disease brains. Use of this marker suggests a large (ca. 70%) loss of cortical and hippocampal GABA terminals in Alzheimer brain. To explain this observation we suggest that neuron loss in this disorder occurs via a process of cortical retrograde degeneration. This scheme reconciles our findings with previous neurochemical measurements on Alzheimer disease brains and also better reconciles the biochemistry with the histology of the disorder.
| Original language | English |
|---|---|
| Pages (from-to) | 192-6 |
| Number of pages | 5 |
| Journal | Neuroscience Letters |
| Volume | 73 |
| Issue number | 2 |
| Publication status | Published - 14 Jan 1987 |
Keywords
- Aged
- Aged, 80 and over
- Alzheimer Disease
- Cerebral Cortex
- Female
- Hippocampus
- Humans
- Male
- Middle Aged
- Synaptosomes
- gamma-Aminobutyric Acid
Fingerprint
Dive into the research topics of 'A disorder of cortical GABAergic innervation in Alzheimer's disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver